نتایج جستجو برای: 1 dna vaccine

تعداد نتایج: 3216706  

Background: Major histocompatibility complex (MHC) is one of the best characterized genetic regions controlling immune responses against vaccines. Identifying the association between MHC haplotypes and improved immune responses would be useful in genetic breeding strategies in animals. OBJECTIVES: MHC class II B genetic diversity and its association with humoral immune responses against Newcast...

Amir Teimourpour Mohsen Arzanlou Roghayeh Teimourpour Samira Rashidian Zahra Meshkat,

Background: Tuberculosis is a life threatening disease that is partially prevented by BCG vaccine. Development of more effective vaccines is an urgent priority in TB control. Ag85a and Tb10.4 are the members of culture filter protein (CFP) of M. tuberculosis that have high immunogenicity. Objective: To analyze the immunogenicity of Ag85a-Tb10.4 DNA vaccine by enzyme-linked immunosorbent as...

2016
Johannes S. Gach Andrea Gorlani Emmanuel Y. Dotsey Juan C. Becerra Chase T. M. Anderson Baiba Berzins Philip L. Felgner Donald N. Forthal Steven G. Deeks Timothy J. Wilkin Joseph P. Casazza Richard A. Koup Christine Katlama Brigitte Autran Robert L. Murphy Chad J. Achenbach

Little is known about the humoral immune response against DNA prime-recombinant adenovirus 5 (rAd5) boost HIV vaccine among HIV-infected patients on long-term suppressive antiretroviral therapy (ART). Previous studies emphasized cellular immune responses; however, current research suggests both cellular and humoral responses are likely required for a successful therapeutic vaccine. Thus, we aim...

2009
Ke Xie Rui-Zhen Bai Yang Wu Quan Liu Kang Liu Yu-Quan Wei

BACKGROUND Vascular endothelial growth factor (VEGF) and its receptor, VEGFR-2 (Flk-1/KDR), play a key role in tumor angiogenesis. Blocking the VEGF-VEGFR-2 pathway may inhibit tumor growth. Here, we used human VEGFR-2 as a model antigen to explore the feasibility of immunotherapy with a plasmid DNA vaccine based on a xenogeneic homologue of this receptor. METHODS The protective effects and t...

2012
Paula Ordonhez Rigato Milton Maciel Adriana Letícia Goldoni Orlando Guerra Piubelli Noemia Mie Orii Ernesto Torres Marques Joseph Thomas August Alberto José da Silva Duarte Maria Notomi Sato

Infants born to HIV-infected mothers are at high risk of becoming infected during gestation or the breastfeeding period. A search is thus warranted for vaccine formulations that will prevent mother-to-child HIV transmission. The LAMP/gag DNA chimeric vaccine encodes the HIV-1 p55gag fused to the lysosome-associated membrane protein-1 (LAMP-1) and has been shown to enhance anti-Gag antibody (Ab)...

Journal: :Avian diseases 2007
Michel L Bunning Patricia E Fox Richard A Bowen Nicholas Komar Gwong-Jen J Chang Tully J Speaker Michael R Stephens Nicole Nemeth Nicholas A Panella Stanley A Langevin Paul Gordy Max Teehee Patricia R Bright Michael J Turell

The New York 1999 strain of West Nile virus (WNV) is nearly 100% fatal in the American crow (Corvus brachyrhynchos). We evaluated four WNV vaccine formulations in American crows, including intramuscular (i.m.) DNA vaccine, i.m. DNA vaccine with adjuvant, orally administered microencapsulated DNA vaccine, and i.m. killed vaccine. Neutralizing antibodies developed in approximately 80% of crows th...

2017
Pengxia Song Shenyi He Aihua Zhou Gang Lv Jingjing Guo Jian Zhou Yali Han Huaiyu Zhou Zhen Hao Hua Cong

BACKGROUND A widely prevalent disease, toxoplasmosis poses serious health threats to both humans and animals; therefore, development of an ideal DNA vaccine against Toxoplasma gondii is needed eagerly. The purpose of the present study is to assess the protective efficacy of a DNA vaccine encoding the T. gondii toxofilin gene (pEGFP-toxofilin). In addition, toxofilin DNA vaccine combined with th...

Journal: :The Journal of infectious diseases 2008
Eric Sandström Charlotta Nilsson Bo Hejdeman Andreas Bråve Göran Bratt Merlin Robb Josephine Cox Thomas Vancott Mary Marovich Richard Stout Said Aboud Muhammad Bakari Kisali Pallangyo Karl Ljungberg Bernard Moss Patricia Earl Nelson Michael Deborah Birx Fred Mhalu Britta Wahren Gunnel Biberfeld

BACKGROUND A human immunodeficiency virus (HIV) vaccine that limits disease and transmission is urgently needed. This clinical trial evaluated the safety and immunogenicity of an HIV vaccine that combines a plasmid-DNA priming vaccine and a modified vaccinia virus Ankara (MVA) boosting vaccine. METHODS Forty healthy volunteers were injected with DNA plasmids containing gp160 of HIV-1 subtypes...

Journal: :Journal of AIDS & clinical research 2015
Jonathan D Fuchs Pierre-Alexandre Bart Nicole Frahm Cecilia Morgan Peter B Gilbert Nidhi Kochar Stephen C DeRosa Georgia D Tomaras Theresa M Wagner Lindsey R Baden Beryl A Koblin Nadine G Rouphael Spyros A Kalams Michael C Keefer Paul A Goepfert Magdalena E Sobieszczyk Kenneth H Mayer Edith Swann Hua-Xin Liao Barton F Haynes Barney S Graham M Juliana McElrath

BACKGROUND Recombinant adenovirus serotype 5 (rAd5)-vectored HIV-1 vaccines have not prevented HIV-1 infection or disease and pre-existing Ad5 neutralizing antibodies may limit the clinical utility of Ad5 vectors globally. Using a rare Ad serotype vector, such as Ad35, may circumvent these issues, but there are few data on the safety and immunogenicity of rAd35 directly compared to rAd5 followi...

2011
Bo-Young Jeon Hyungjin Eoh Sang-Jun Ha Hyeeun Bang Seung-Cheol Kim Young-Chul Sung Sang-Nae Cho

PURPOSE Bacillus Calmette-Guérin (BCG) vaccine has widely been used to immunize against tuberculosis, but its protective efficacy is variable in adult pulmonary tuberculosis, while it is not efficiently protective against progressive infection of virulent Mycobacterium tuberculosis strains. In this study, the protective effects of plasmid DNA vaccine constructs encoding IL-12 or IL-18 with the ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید